Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech CEO
Pharma
Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia
The Padcev-Keytruda combo notched another phase 3 win. China didn't renew an Alzheimer's drug's conditional nod. Fosun out-licensed a DPP1 inhibitor.
Angus Liu
Aug 15, 2025 8:31am
ElevAAte and the push for East Asian American biopharma leaders
May 2, 2025 12:28pm
Jazz reviewing M&A deal options of 'various sizes,' CFO says
Feb 26, 2025 11:08am
Moderna CEO confronts challenges for RSV, COVID businesses
Jan 7, 2025 11:00am
Autoimmune drugmaker Aurinia lays off 45% of workforce
Nov 7, 2024 9:44am
Turbulent times at Aurinia with renewed investor activism
Aug 13, 2024 11:30am
